MOUNTAIN VIEW, Calif., April 26, 2012 (GLOBE NEWSWIRE) -- Conceptus, Inc. (Nasdaq:CPTS), developer of the Essure® procedure, the leading non-surgical permanent birth control method, today reported financial results for the three months ended March 31, 2012 and revised financial guidance for 2012.
